Literature DB >> 18658150

SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E.

Rakhi Agarwal1, Subramanyam Swaminathan.   

Abstract

Clostridium botulinum neurotoxins are the most potent toxins to humans. The recognition and cleavage of SNAREs are prime evente in exhibiting their toxicity. We report here the crystal structure of the catalytically active full-length botulinum serotype E catalytic domain (BoNT E) in complex with SNAP-25 (a SNARE protein) substrate peptide Arg(180)-Ile(181)-Met(182)-Glu(183) (P1-P3'). It is remarkable that the peptide spanning the scissile bond binds to but bypasses cleavage by the enzyme and inhibits the catalysis fairly with K(i) approximately 69 microm. The inhibitory peptide occupies the active site of BoNT E and shows well defined electron density. The catalytic zinc and the conserved key residue Tyr(350) of the enzyme facilitate the docking of Arg(180) (P1) by interacting with its carbonyl oxygen that displaces the nucleophilic water. The general base Glu(212) side chain interacts with the main chain amino group of P1 and P1'. Conserved Arg(347) of BoNT E stabilizes the proper docking of the Ile(181) (P1') main chain, whereas the hydrophobic pockets stabilize the side chains of Ile(181) (P1') and Met(182) (P2'), and the 250 loop stabilizes Glu(183) (P3'). Structural and functional analysis revealed an important role for the P1' residue and S1' pocket in driving substrate recognition and docking at the active site. This study is the first of its kind and rationalizes the substrate cleavage strategy of BoNT E. Also, our complex structure opens up an excellent opportunity of structure-based drug design for this fast acting and extremely toxic high priority BoNT E.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18658150      PMCID: PMC2533769          DOI: 10.1074/jbc.M803756200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution.

Authors:  M A Hanson; R C Stevens
Journal:  Nat Struct Biol       Date:  2000-08

2.  Cloning, high level expression, purification, and crystallization of the full length Clostridium botulinum neurotoxin type E light chain.

Authors:  Rakhi Agarwal; Subramaniam Eswaramoorthy; Desigan Kumaran; John J Dunn; Subramanyam Swaminathan
Journal:  Protein Expr Purif       Date:  2004-03       Impact factor: 1.650

3.  Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity.

Authors:  Brent Segelke; Mark Knapp; Saloumeh Kadkhodayan; Rod Balhorn; Bernhard Rupp
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-23       Impact factor: 11.205

4.  Catalytic features of the botulinum neurotoxin A light chain revealed by high resolution structure of an inhibitory peptide complex.

Authors:  Nicholas R Silvaggi; David Wilson; Saul Tzipori; Karen N Allen
Journal:  Biochemistry       Date:  2008-05-06       Impact factor: 3.162

5.  Development of potent inhibitors of botulinum neurotoxin type B.

Authors:  Christine Anne; Serge Turcaud; Jean Quancard; Franck Teffo; Hervé Meudal; Marie-Claude Fournié-Zaluski; Bernard P Roques
Journal:  J Med Chem       Date:  2003-10-23       Impact factor: 7.446

6.  Small tripeptide surrogates with low nanomolar affinity as potent inhibitors of the botulinum neurotoxin B metallo-proteolytic activity.

Authors:  Armand Blommaert; Serge Turcaud; Christine Anne; Bernard P Roques
Journal:  Bioorg Med Chem       Date:  2004-06-01       Impact factor: 3.641

7.  Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics.

Authors:  Jiafu Wang; Jianghui Meng; Gary W Lawrence; Tomas H Zurawski; Astrid Sasse; MacDara O Bodeker; Marcella A Gilmore; Ester Fernández-Salas; Joseph Francis; Lance E Steward; K Roger Aoki; J Oliver Dolly
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

8.  Structural analysis of botulinum neurotoxin type E catalytic domain and its mutant Glu212-->Gln reveals the pivotal role of the Glu212 carboxylate in the catalytic pathway.

Authors:  Rakhi Agarwal; Subramaniam Eswaramoorthy; Desigan Kumaran; Thomas Binz; Subramanyam Swaminathan
Journal:  Biochemistry       Date:  2004-06-01       Impact factor: 3.162

9.  Purification and amino acid composition of type E botulinum neurotoxin.

Authors:  B R DasGupta; S Rasmussen
Journal:  Toxicon       Date:  1983       Impact factor: 3.033

Review 10.  Neurotoxins affecting neuroexocytosis.

Authors:  G Schiavo; M Matteoli; C Montecucco
Journal:  Physiol Rev       Date:  2000-04       Impact factor: 37.312

View more
  8 in total

Review 1.  Unique ganglioside binding by botulinum neurotoxins C and D-SA.

Authors:  Abby R Kroken; Andrew P-A Karalewitz; Zhuji Fu; Michael R Baldwin; Jung-Ja P Kim; Joseph T Barbieri
Journal:  FEBS J       Date:  2011-05-31       Impact factor: 5.542

2.  Basic tetrapeptides as potent intracellular inhibitors of type A botulinum neurotoxin protease activity.

Authors:  Martha Hale; George Oyler; Subramanyam Swaminathan; S Ashraf Ahmed
Journal:  J Biol Chem       Date:  2010-10-20       Impact factor: 5.157

3.  Light chain separated from the rest of the type a botulinum neurotoxin molecule is the most catalytically active form.

Authors:  Nizamettin Gul; Leonard A Smith; S Ashraf Ahmed
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

4.  New Steroidal 4-Aminoquinolines Antagonize Botulinum Neurotoxin Serotype A in Mouse Embryonic Stem Cell Derived Motor Neurons in Postintoxication Model.

Authors:  Jelena Konstantinović; Erkan Kiris; Krishna P Kota; Johanny Kugelman-Tonos; Milica Videnović; Lisa H Cazares; Nataša Terzić Jovanović; Tatjana Ž Verbić; Boban Andjelković; Allen J Duplantier; Sina Bavari; Bogdan A Šolaja
Journal:  J Med Chem       Date:  2018-02-06       Impact factor: 7.446

5.  Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F.

Authors:  Rakhi Agarwal; James J Schmidt; Robert G Stafford; Subramanyam Swaminathan
Journal:  Nat Struct Mol Biol       Date:  2009-06-21       Impact factor: 15.369

Review 6.  Clostridial neurotoxins: mechanism of SNARE cleavage and outlook on potential substrate specificity reengineering.

Authors:  Thomas Binz; Stefan Sikorra; Stefan Mahrhold
Journal:  Toxins (Basel)       Date:  2010-04-13       Impact factor: 4.546

7.  Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide.

Authors:  Mal-Gi Choi; Mi Jin Kim; Do-Geun Kim; Ri Yu; You-Na Jang; Won-Jong Oh
Journal:  PLoS One       Date:  2018-04-02       Impact factor: 3.240

Review 8.  Evolutionary Features in the Structure and Function of Bacterial Toxins.

Authors:  Raj Kumar; Thomas M Feltrup; Roshan V Kukreja; Kruti B Patel; Shuowei Cai; Bal Ram Singh
Journal:  Toxins (Basel)       Date:  2019-01-03       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.